Rayno Life Science Portfolios: 2010 Performance
Diagnostics and Tools 2010 Original Price Price % Ret Recomm YrEnd'10 Abaxis ABAX 2/2/09 15 26.85 79 CardioV.Sys. CSII 11/5/10 7.15 11.66 63 Celera CRA 3/28/10 7 6.3 -10 Exact Sci EXAS 12/10/10 5.6 5.98 6.8 GenProbe GPRO 2/2/09 45 58.35 29.7 Illumina ILMN 2/2/09 29 63.34 118 Immucor BLUD 4/5/10...
Who Knew “Land Banks” Were Off-Balance Sheet?
It was 2005, the peak of the housing bubble and housing stocks were running wild. Toll Brothers (TOL) and Lennar (LEN) stock were at 60. There was no end to housing with Wall Street buying up mortgages faster than brokers could sell them. One of the many creative ploys feeding the frenzy was...
Rayno Life Science Portfolios 2010- Another Excellent Year!
The Life Science Sector (^BTK) Overall Has Outperformed Other Major Market Indices Over 10 Years As we approach year-end we can look back on a great year for all markets and outperformance for the Life Science sector. Benchmark ETF performance is as follows YTD: FBT up 38.8%, IBB up 15.4%, XBI...
‘Tis the Season for Microcaps: Corgenix(CONX.OB), ImmuCell (ICCC) and IVAX (IVD)
Three Value Stocks Off The Radar Screen At this time of the year, especially when the market has a bullish tone, small (IWM) and mid cap (MDY) stocks are likely to outperform-YTD they are up about 25%. MicroCaps also tend to do well in the Q4-Q1 time frame because investors tend to be less...
Vermillion Soars on a Quiet Day: VRML $9 Up 23.2%
Vermillion (VRML) continues its wild ride upward from the November low of $4.53 on heavy volume of 546K shares with no apparent news. Two analysts cover the stock with a buy/outperform and Revenue Forecasts in the $7M range for Year Ending Dec.'11 and a Price Target of 10. The market cap is...